MCID: TCH005
MIFTS: 18

Tièche-Jadassohn Nevus malady

Categories: Rare diseases, Neuronal diseases, Skin diseases

Aliases & Classifications for Tièche-Jadassohn Nevus

Aliases & Descriptions for Tièche-Jadassohn Nevus:

Name: Tièche-Jadassohn Nevus 50
Benign Mesenchymal Melanoma 50
Jadassohn-Tièche Syndrome 50
Jadassohn-Tièche Nevus 50
Blue Neuronevus 50
Mongolian Spot 69
Nevus, Blue 69
Blue Nevus 50

Classifications:



Summaries for Tièche-Jadassohn Nevus

MalaCards based summary : Tièche-Jadassohn Nevus, also known as benign mesenchymal melanoma, is related to carney complex variant and melanoma. The drugs Warfarin and Edetic Acid have been mentioned in the context of this disorder. Affiliated tissues include skin.

Wikipedia : 71 Blue nevus (also known as \"blue neuronevus,\" \"dermal melanocytoma,\" and \"nevus bleu\") is a type of... more...

Related Diseases for Tièche-Jadassohn Nevus

Diseases related to Tièche-Jadassohn Nevus via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 24)
id Related Disease Score Top Affiliating Genes
1 carney complex variant 10.9
2 melanoma 10.2
3 nevus of ota 10.1
4 mongolian spot 9.9
5 cutis verticis gyrata 9.8
6 orbital melanoma 9.8
7 melanoma metastasis 9.8
8 spitz nevus 9.8
9 sarcoma 9.8
10 argyria 9.8
11 clear cell sarcoma 9.8
12 lupus erythematosus 9.6
13 alopecia areata 9.6
14 albinism 9.6
15 lentigo maligna melanoma 9.6
16 alopecia 9.6
17 phacomatosis pigmentovascularis 9.6
18 cutaneous lupus erythematosus 9.6
19 pyogenic granuloma 9.6
20 ocular albinism 9.6
21 paraganglioma 9.6
22 subacute cutaneous lupus erythematosus 9.6
23 adenocarcinoma 9.6
24 hidradenoma 9.6

Graphical network of the top 20 diseases related to Tièche-Jadassohn Nevus:



Diseases related to Tièche-Jadassohn Nevus

Symptoms & Phenotypes for Tièche-Jadassohn Nevus

Drugs & Therapeutics for Tièche-Jadassohn Nevus

Drugs for Tièche-Jadassohn Nevus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 65)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Warfarin Approved Phase 3 81-81-2 6691 54678486
2
Edetic Acid Approved, Vet_approved Phase 3,Phase 2 60-00-4, 62-33-9 6049
3
Dabrafenib Approved Phase 3,Phase 2 44462760 44516822
4
Trametinib Approved Phase 3,Phase 2 871700-17-3 11707110
5
nivolumab Approved Phase 3,Phase 2 946414-94-4
6
Apixaban Approved Phase 3 503612-47-3 10182969
7 Dabigatran Phase 3
8
protease inhibitors Phase 3
9 Chelating Agents Phase 3,Phase 2
10 Serine Proteinase Inhibitors Phase 3
11 Technetium Tc 99m Pentetate Phase 3,Phase 2
12 HIV Protease Inhibitors Phase 3
13 Dextrans Phase 3,Phase 2
14 Pentetic Acid Phase 3,Phase 2
15 Plasma Substitutes Phase 3,Phase 2
16 Anticoagulants Phase 3,Phase 2
17 Protein Kinase Inhibitors Phase 3,Phase 2,Phase 1
18 Radiopharmaceuticals Phase 3,Phase 2
19 Blood Substitutes Phase 3,Phase 2
20 Antithrombin III Phase 3
21 Antithrombins Phase 3
22 Immunoglobulins Phase 3,Phase 2
23 Antibodies, Monoclonal Phase 3,Phase 2
24 Antibodies Phase 3,Phase 2
25 interferons Phase 3
26 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 3
27 Hypolipidemic Agents Phase 3
28 Anti-Infective Agents Phase 3
29 Anticholesteremic Agents Phase 3
30 Interferon-alpha Phase 3
31 Lipid Regulating Agents Phase 3
32 Antimetabolites Phase 3
33 Antiviral Agents Phase 3
34 Factor Xa Inhibitors Phase 3
35 serine Nutraceutical Phase 3
36 Nutmeg Nutraceutical Phase 3
37 Omega 3 Fatty Acid Nutraceutical Phase 3
38 Mace Nutraceutical Phase 3
39
Aminolevulinic acid Approved Phase 2 106-60-5 137
40
Bevacizumab Approved, Investigational Phase 2 216974-75-3
41 Dermatologic Agents Phase 2
42 Vaccines Phase 2,Phase 1
43 Pharmaceutical Solutions Phase 1, Phase 2
44 Photosensitizing Agents Phase 2
45 Mitogens Phase 2
46 Angiogenesis Inhibitors Phase 2
47 Angiogenesis Modulating Agents Phase 2
48 Endothelial Growth Factors Phase 2
49 Immunoglobulin G Phase 2
50 Orange Nutraceutical Phase 1, Phase 2

Interventional clinical trials:

(show all 28)
id Name Status NCT ID Phase
1 Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes Completed NCT01106040 Phase 3
2 Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma Completed NCT00671918 Phase 3
3 Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate Completed NCT00262600 Phase 3
4 Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma Recruiting NCT02224781 Phase 3
5 Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Recruiting NCT02339571 Phase 2, Phase 3
6 Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Active, not recruiting NCT01274338 Phase 3
7 Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia Active, not recruiting NCT02104817 Phase 3
8 Phase III Acute Coronary Syndrome Terminated NCT00831441 Phase 3
9 Fluorescein for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Stage I and II Malignant Melanoma Completed NCT00847522 Phase 1, Phase 2
10 Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma Completed NCT00101166 Phase 2
11 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
12 Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery Recruiting NCT02196181 Phase 2
13 Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Recruiting NCT01950390 Phase 2
14 Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome Active, not recruiting NCT02258243 Phase 2
15 A Study Comparing Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping Active, not recruiting NCT02509598 Phase 2
16 Second Echelon Node Study With Methylene Blue Completed NCT01823172 Phase 1
17 An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma Completed NCT01078961 Phase 1
18 Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy Completed NCT00700167 Phase 1
19 Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome Completed NCT02157623
20 Infrared Lymphangiography as a Method of Sentinel Node Identification Completed NCT02057393
21 Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue Completed NCT00581698
22 Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma Completed NCT01898403
23 Sentinel Node With Ultrasound Contrast in Melanoma Completed NCT00370136
24 Lymphatic Anomalies Registry Recruiting NCT02399527
25 Family Study of Melanoma in Italy Recruiting NCT00339222
26 Registry for Vascular Anomalies Associated With Coagulopathy Recruiting NCT00576888
27 Fluorescence Surgery for Sentinel Node Identification in Melanoma Recruiting NCT02142244
28 Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ Not yet recruiting NCT03025724

Search NIH Clinical Center for Tièche-Jadassohn Nevus

Genetic Tests for Tièche-Jadassohn Nevus

Anatomical Context for Tièche-Jadassohn Nevus

MalaCards organs/tissues related to Tièche-Jadassohn Nevus:

39
Skin

Publications for Tièche-Jadassohn Nevus

Variations for Tièche-Jadassohn Nevus

Expression for Tièche-Jadassohn Nevus

Search GEO for disease gene expression data for Tièche-Jadassohn Nevus.

Pathways for Tièche-Jadassohn Nevus

GO Terms for Tièche-Jadassohn Nevus

Sources for Tièche-Jadassohn Nevus

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....